Quest Services Inc
-
Services:
- Specially designed program for DUI/DWI clients
- State department of health
- State Substance use treatment agency
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Aftercare/continuing care
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
- Mental health services
- Social skills development
- Transportation assistance
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Group counseling
- Marital/couples counseling
- Children/Adolescents
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Vaping permitted in designated area
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Outpatient
- Intensive outpatient treatment
- Sign language services for the deaf and hard of hearing
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Male
- Female
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- SAMHSA funding/block grants
- Federal, or any government funding for substance use treatment programs
- Private health insurance
- Medicaid
- Buprenorphine maintenance
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Prescribes naltrexone
- Prescribes buprenorphine
- No formal relationship with prescribing entity
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- HIV testing
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- TB screening
- Testing for Hepatitis C (HCV)
- Smoking permitted in designated area
- Treatment for other addiction disorder
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Acamprosate (Campral®)
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Clonidine
- Screening for substance use
- Comprehensive substance use assessment
- Screening for mental disorders
- Screening for tobacco use
- Interim services for clients
- Comprehensive mental health assessment
- Telemedicine/telehealth therapy
- Anger management
- Brief intervention
- Substance use disorder counseling
- Cognitive behavioral therapy
- Trauma-related counseling
- Relapse prevention
- Matrix Model
- Contingency management/motivational incentives
- Motivational interviewing
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Mentoring/peer support
- Assistance with obtaining social services
- Housing services
- Adult men
- Young adults
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Adult women
- No formal relationship with prescribing entity
- Private for-profit organization
Exclusive Services
License/Certification/Accreditation
Transitional Services
Ancillary Services
Education and Counseling Services
Age Groups Accepted
Type of Care
Facility Vaping Policy
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Language Services
Opioid Medications used in Treatment
Gender Accepted
Payment/Insurance/Funding Accepted
Type of Opioid Treatment
External Opioid Medications Source
Testing
Facility Smoking Policy
Other Services
Pharmacotherapies
Assessment/Pre-treatment
Treatment Approaches
Type of Alcohol Use Disorder Treatment
Recovery Support Services
Special Programs/Groups Offered
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)






